|
Market Closed -
Nasdaq
16:00:00 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.3933 USD | -1.01% |
|
+2.66% | -86.25% |
| 07-15 | Immutep highlights encouraging survival data and key clinical milestones | FI |
| 07-14 | Immutep Granted New US Patent for Cancer Treatment Methods | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUTEP LIMITED | Other Biotechnology & Medical Research | -1.01% | +2.66% | -86.25% | -77.78% | -87.59% | 53.51M |
- Stock Market
- Stocks
- IMM Stock
- IMMP Stock
- Charts Immutep Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















